1. Home
  2. MBIO vs STRR Comparison

MBIO vs STRR Comparison

Compare MBIO & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • STRR
  • Stock Information
  • Founded
  • MBIO 2015
  • STRR 1985
  • Country
  • MBIO United States
  • STRR United States
  • Employees
  • MBIO N/A
  • STRR N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • MBIO Health Care
  • STRR Health Care
  • Exchange
  • MBIO Nasdaq
  • STRR Nasdaq
  • Market Cap
  • MBIO 7.3M
  • STRR 6.3M
  • IPO Year
  • MBIO N/A
  • STRR N/A
  • Fundamental
  • Price
  • MBIO $1.17
  • STRR $2.49
  • Analyst Decision
  • MBIO Strong Buy
  • STRR
  • Analyst Count
  • MBIO 1
  • STRR 0
  • Target Price
  • MBIO $100.00
  • STRR N/A
  • AVG Volume (30 Days)
  • MBIO 1.1M
  • STRR 19.0K
  • Earning Date
  • MBIO 05-20-2025
  • STRR 05-14-2025
  • Dividend Yield
  • MBIO N/A
  • STRR N/A
  • EPS Growth
  • MBIO N/A
  • STRR N/A
  • EPS
  • MBIO N/A
  • STRR N/A
  • Revenue
  • MBIO N/A
  • STRR $53,359,000.00
  • Revenue This Year
  • MBIO N/A
  • STRR $43.37
  • Revenue Next Year
  • MBIO N/A
  • STRR $23.60
  • P/E Ratio
  • MBIO N/A
  • STRR N/A
  • Revenue Growth
  • MBIO N/A
  • STRR 16.54
  • 52 Week Low
  • MBIO $1.01
  • STRR $1.72
  • 52 Week High
  • MBIO $65.00
  • STRR $5.35
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 39.20
  • STRR 66.99
  • Support Level
  • MBIO $1.01
  • STRR $2.14
  • Resistance Level
  • MBIO $1.22
  • STRR $2.14
  • Average True Range (ATR)
  • MBIO 0.09
  • STRR 0.23
  • MACD
  • MBIO 0.03
  • STRR 0.05
  • Stochastic Oscillator
  • MBIO 41.89
  • STRR 85.39

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About STRR Star Equity Holdings Inc.

Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.

Share on Social Networks: